|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/4704 | (2013.01) | ||
| A61K 31/4704 | (2006.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 9/4858 | (2013.01) |
| (11) | Number of the document | 3603634 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19180535.7 |
| Date of filing the European patent application | 2005-05-17 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2025-02-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0411056 | 2004-05-18 | GB |
| (72) |
Collingwood, Stephen Paul , GB
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH , Brunner Strasse 59, 1230 Wien, AT |
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING GLYCOPYRROLATE AND A BETA2 ADRENOCEPTOR AGONIST |
| PHARMACEUTICAL COMPOSITION CONTAINING GLYCOPYRROLATE AND A BETA2 ADRENOCEPTOR AGONIST |